approval
saveNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
community read0 votes
Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- approvalNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE) — FDA approvalMar 26, 2026 · 192d ago
- approvalNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalFeb 6, 2026 · 240d ago
- approvalNOREPINEPHRINE BITARTRATE — FDA approvalDec 11, 2025 · 297d ago
- approvalNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalJun 11, 2024 · 845d ago
- approvalNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalNov 23, 2023 · 1046d ago
- approvalNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalJun 2, 2022 · 1585d ago
- approvalNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalJan 15, 2021 · 2088d ago
same company · ±60 days · 3
🐶 often sniffed alongside
top 7- drugNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE34 co-mentions · 13 sources
- drugNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE34 co-mentions · 13 sources
- drugNorepinephrine Bitartrate Baxter34 co-mentions · 13 sources
- drugnorepinephrine34 co-mentions · 13 sources
- tagApproval32 co-mentions · 9 sources
- drugRNS-6018 co-mentions · 10 sources
- tagRecall4 co-mentions · 4 sources
comments(0)
5-min edit window · permanent after that